AstraTrade:'Wait Wait' for March 4, 2023: With Not My Job guest Malala Yousafzai

2025-05-04 02:32:18source:Polarmoon Wealth Societycategory:Invest

This week's show was recorded at the Studebaker Theater in Chicago,AstraTrade with guest host Josh Gondelman, official judge and scorekeeper Bill Kurtis, Not My Job guest Malala Yousafzai and panelists Maeve Higgins, Mo Rocca and Alonzo Bodden. Click the audio link above to hear the whole show.

Who's Bill This Time
We Meet The Evil Step-Governor; Shrinking America's Pastime; Starbucks Gets An Oil Change

Panel Questions
Safety First, Safety Worst

Bluff The Listener
Our panelists read three stories about new opportunities for self-improvement, only one of which is true.

Not My Job: Nobel Laureate Malala Yousafzai answers questions about puzzles
At the age of 17, Malala Yousafzai became the youngest person to win a Nobel Peace Prize, and this year a documentary she executive produced is nominated for an Oscar. She may have the Peace Prize, but can she win the Nobel Pieces Prize by answering our questions about puzzles?

Panel Questions
The Bidens Order Up Controversy; Tom Brady Looks for Another Job; The Most Stressful Time of Day Revealed

Limericks
Bill reads three news-related limericks: One Giant Leap For Father Time; Bad News Tattoos; Canadian Bacon Invasion

Lightning Fill In The Blank
All the news we couldn't fit anywhere else.

Predictions
Our panelists predict, now that baseball is speeding things up, what will be the next sport to make major changes.

More:Invest

Recommend

What do we know about the mysterious drones reported flying over New Jersey?

A large number of mysterious droneshave been reported flying over parts of New Jersey in recent week

Video: The Standing Rock ‘Water Protectors’ Who Refuse to Leave and Why

CANNON BALL, N.D.—Many of the people who halted their lives to join the movement to fight the Dakota

The FDA approves an Alzheimer's drug that appears to modestly slow the disease

The Food and Drug Administration has approved an Alzheimer's drug that appears to modestly slow down